Adaptive Phage Therapeutics, Inc.

Pharmaceutical company · Gaithersburg, Maryland, United States

Adaptive Phage Therapeutics, Inc. is a pharmaceutical company headquartered in Gaithersburg, Maryland, United States. Its earliest recorded incorporation is in 2017. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $296,787 in total, most recently in 2021. It has reported private securities offerings to the US SEC, most recently $12 million sold in a notice filed in 2023.

www.aphage.comProfile compiled from public records. Is this your company? Request a correction or update

Adaptive Phage Therapeutics at a glance

Typepharmaceutical company
HeadquartersGaithersburg, Maryland, United States
Earliest incorporation on record2017
Employees (self-reported, 2021)26
SEC CIK1701259

What does Adaptive Phage Therapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $296,787 in total (2021).

Private fundraising reported to the SEC

8 Form D notices; the most recent reported $12 million sold (2023).

Frequently asked questions about Adaptive Phage Therapeutics

Where is Adaptive Phage Therapeutics headquartered?

Adaptive Phage Therapeutics, Inc. is headquartered in Gaithersburg, Maryland, United States.

What does Adaptive Phage Therapeutics do?

Adaptive Phage Therapeutics, Inc. is a pharmaceutical company.

When was Adaptive Phage Therapeutics founded?

The earliest incorporation on record for Adaptive Phage Therapeutics, Inc. is in 2017, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences